FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975877581> ?p ?o ?g. }

• W1975877581 endingPage "3026" @default.
• W1975877581 startingPage "2991" @default.
• W1975877581 abstract "Type 2 diabetes mellitus typically involves abnormal beta-cell function that results in relative insulin deficiency, insulin resistance accompanied by decreased glucose transport into muscle and fat cells, and increased hepatic glucose output, all of which contribute to hyperglycemia.This review examines the pharmacology, pharmacokinetics, drug-interaction potential, adverse effects, and dosing guidelines for metformin hydrochloride, a biguanide agent for the treatment of type 2 diabetes. Clinical trial data are reviewed, including efficacy and tolerability information, with a focus on studies of dual metformin therapy (metformin plus another oral agent or insulin) published from 1998 to the present. Pharmacoeconomic considerations are also discussed.Primary research and review articles were identified through a search of MEDLINE (1966-May 2003) and International Pharmaceutical Abstracts (1970-May 2003) using the terms metformin and/or Glucophage. Web of Science (1995-May 2003) was used to search for additional abstracts. The package inserts for metformin and metformin combination products were consulted. All identified articles and abstracts were assessed for relevance, and all relevant information was included. Priority was given to the primary medical literature and clinical trial reports.Metformin is the only currently available oral antidiabetic/hypoglycemic agent that acts predominantly by inhibiting hepatic glucose release. Because patients with type 2 diabetes often have excess hepatic glucose output, use of metformin is effective in lowering glycosylated hemoglobin (HbA1c) by 1 to 2 percentage points when used as monotherapy or in combination with other blood glucose-lowering agents or insulin. Other metabolic variables (eg, dyslipidemia, fibrinolysis) may be improved with the use of metformin. Body weight is often maintained or slightly reduced from baseline. Metformin is well tolerated and is associated with few clinically deleterious adverse events. The most important and potentially life-threatening adverse event associated with its use is lactic acidosis, which occurs very rarely.Metformin has multiple benefits in patients with type 2 diabetes. It can effectively lower HbA1c values, positively affect lipid profiles, and improve vascular and hemodynamic indices. Adverse effects are generally tolerable and self-limiting. The availability of products combining metformin with a sulfonylurea or rosiglitazone has expanded the array of therapies for the management of type 2 diabetes." @default.
• W1975877581 created "2016-06-24" @default.
• W1975877581 creator A5007314577 @default.
• W1975877581 creator A5030099154 @default.
• W1975877581 creator A5086320017 @default.
• W1975877581 creator A5087170338 @default.
• W1975877581 date "2003-12-01" @default.
• W1975877581 modified "2023-09-30" @default.
• W1975877581 title "Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy" @default.
• W1975877581 cites W110733232 @default.
• W1975877581 cites W1584324651 @default.
• W1975877581 cites W1964423574 @default.
• W1975877581 cites W1967156178 @default.
• W1975877581 cites W1968062717 @default.
• W1975877581 cites W1979110885 @default.
• W1975877581 cites W1983464930 @default.
• W1975877581 cites W1983716848 @default.
• W1975877581 cites W1987672280 @default.
• W1975877581 cites W1987682269 @default.
• W1975877581 cites W1993252892 @default.
• W1975877581 cites W1995404454 @default.
• W1975877581 cites W1998010136 @default.
• W1975877581 cites W1999398484 @default.
• W1975877581 cites W2009804272 @default.
• W1975877581 cites W2013253832 @default.
• W1975877581 cites W2015249405 @default.
• W1975877581 cites W2016705514 @default.
• W1975877581 cites W2018568241 @default.
• W1975877581 cites W2019017315 @default.
• W1975877581 cites W2020831729 @default.
• W1975877581 cites W2022914096 @default.
• W1975877581 cites W2027804378 @default.
• W1975877581 cites W2028038659 @default.
• W1975877581 cites W2035601571 @default.
• W1975877581 cites W2036731511 @default.
• W1975877581 cites W2043316108 @default.
• W1975877581 cites W2050154789 @default.
• W1975877581 cites W2050191746 @default.
• W1975877581 cites W2051006205 @default.
• W1975877581 cites W2055518481 @default.
• W1975877581 cites W2055682358 @default.
• W1975877581 cites W2056347227 @default.
• W1975877581 cites W2058824697 @default.
• W1975877581 cites W2059649085 @default.
• W1975877581 cites W2061694846 @default.
• W1975877581 cites W2062632254 @default.
• W1975877581 cites W2066424080 @default.
• W1975877581 cites W2069150029 @default.
• W1975877581 cites W2071723829 @default.
• W1975877581 cites W2076693232 @default.
• W1975877581 cites W2089662453 @default.
• W1975877581 cites W2090001313 @default.
• W1975877581 cites W2094083143 @default.
• W1975877581 cites W2102382908 @default.
• W1975877581 cites W2108928850 @default.
• W1975877581 cites W2113539958 @default.
• W1975877581 cites W2114391822 @default.
• W1975877581 cites W2118243882 @default.
• W1975877581 cites W2127352898 @default.
• W1975877581 cites W2128912053 @default.
• W1975877581 cites W2134126803 @default.
• W1975877581 cites W2134315188 @default.
• W1975877581 cites W2138226825 @default.
• W1975877581 cites W2138851319 @default.
• W1975877581 cites W2140090067 @default.
• W1975877581 cites W2146089205 @default.
• W1975877581 cites W2146986980 @default.
• W1975877581 cites W2150312049 @default.
• W1975877581 cites W2151921086 @default.
• W1975877581 cites W2154909966 @default.
• W1975877581 cites W2155334925 @default.
• W1975877581 cites W2158822657 @default.
• W1975877581 cites W2161538498 @default.
• W1975877581 cites W2162766735 @default.
• W1975877581 cites W2167556067 @default.
• W1975877581 cites W2169563211 @default.
• W1975877581 cites W2169735327 @default.
• W1975877581 cites W2169775081 @default.
• W1975877581 cites W2171607733 @default.
• W1975877581 cites W2188846692 @default.
• W1975877581 cites W2196515255 @default.
• W1975877581 cites W2315903617 @default.
• W1975877581 cites W2315982688 @default.
• W1975877581 cites W2337454357 @default.
• W1975877581 cites W2339564060 @default.
• W1975877581 cites W2345930727 @default.
• W1975877581 cites W2414395994 @default.
• W1975877581 cites W2769264260 @default.
• W1975877581 cites W2786617581 @default.
• W1975877581 cites W3122152400 @default.
• W1975877581 cites W4233562854 @default.
• W1975877581 cites W4251317500 @default.
• W1975877581 cites W4254177295 @default.
• W1975877581 doi "https://doi.org/10.1016/s0149-2918(03)90089-0" @default.
• W1975877581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14749143" @default.
• W1975877581 hasPublicationYear "2003" @default.
• W1975877581 type Work @default.
• W1975877581 sameAs 1975877581 @default.

• next